-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Xylem, Lowers Price Target to $135

Benzinga·10/14/2026 14:19:54
语音播报
RBC Capital analyst Jeffrey Reive maintains Xylem (NYSE:XYL) with a Outperform and lowers the price target from $164 to $135.